Results 61 to 70 of about 53,102 (149)

Patients with metabolic dysfunction-associated steatotic liver disease have preserved in vitro responses to antiplatelet drugs. [PDF]

open access: yesRes Pract Thromb Haemost, 2023
van den Boom BP   +4 more
europepmc   +1 more source

Mechanisms and recent advances in non-coding RNAs and RNA modifications in antiplatelet drug resistance

open access: yesFrontiers in Genetics
The high incidence and mortality rates of cardiovascular and cerebrovascular diseases make them a significant global health challenge. Antiplatelet drugs play a central role in the prevention and treatment of these diseases.
Ping Ni   +15 more
doaj   +1 more source

The impact of platelets and antiplatelets medications on immune mediation

open access: yesJVS - Vascular Science
Objective: To investigate the mechanisms through which platelets and antiplatelet therapies modulate the immune response and propose directions for future research in this field, with a particular emphasis on their impact on treatment efficacy and ...
Leela Morena, MD   +11 more
doaj   +1 more source

Analysis of the structure of consumption of antiplatelet drugs in the Russian pharmaceutical market: 2014-2016

open access: yesКачественная клиническая практика, 2018
This article analyzes the volume of the Russian pharmaceutical market of antiplatelet drugs in the period 2014-2016. 80% of patients take clopidogrel generics, giving preference to Zilt®.
S. K. Zyryanov, E. V. Dumchenko
doaj  

Oral anticoagulants or antiplatelet drugs after heart valve reconstructive surgery: modern guidelines for the practitioners

open access: yesРоссийский кардиологический журнал
After heart valve surgery, anticoagulant therapy is usually recommended. The duration and necessity of combining oral anticoagulants with antiplatelet drugs depends on the type of manipulation performed, patient comorbidity and some other factors ...
V. P. Kuzmin   +7 more
doaj   +1 more source

Antiplatelet drugs and breast cancer risk in a large nationwide Danish case-control study. [PDF]

open access: yesInt J Cancer, 2023
Cairat M   +5 more
europepmc   +1 more source

Antithrombotic Effects of Fostamatinib in Combination with Conventional Antiplatelet Drugs. [PDF]

open access: yesInt J Mol Sci, 2022
Harbi MH   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy